3Otter J A. Superbug:the fatal menace of MRSA[J].Lancet InfectDis,2010,(8):519-520.
4Otter J A,French G L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe[J].{H}LANCET INFECTIOUS DISEASES,2010,(4):227-239.
5张若渔.“史上最严”能否遏制抗生素的滥用.
6Kardar S S. Antibiotic resistance:New approaches to a historical problem[EB/OL].http://www.actionbioscience.org/newfrontiers/kardar,2008.
7Goossens H,Guillemot D,Ferech M. National campaigns to improve antibiotic use[J].{H}EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,2006.373-379.
8Goossens H. Antibiotic consumption and link to resistance[J].{H}Clinical Microbiology and Infection,2009.12-15.
9Zaidi A K,Huskins W C,Thaver D. Hospital-acquired neonatal infections in developing countries[J].{H}LANCET,2005.1175-1188.
10Vicente M,Hodgson J,Massidda O. The fallacies of hope:will we discover new antibiotics to combat pathogenic bacteria in time[J].{H}FEMS Microbiology Reviews,2006.841-852.
